Business
Bausch + Lomb Announces Refinancing of Outstanding Term B Loans
VAUGHAN, Ontario, December 12, 2025--Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb" or the "company"), a leading global eye health company dedicated to helping people see better to live better, today announced that it allocated a $2,802,125,000 tranche (the "Replacement Term Loans") of new term B loans, the proceeds of which will be used to refinance all of its outstanding term B loans due 2031 (the "Third Amendment Term Loans") and its outstanding term B loans due 2028 (the "First
About this update from Bausch + Lomb Corporation
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":4152,"height":327,"url":"https://media.zenfs.com/en/business-wire.com/9bb124061c0ae7576bb9f1adcd2479e3"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/k632mq4Itw5Y29w3s48MkQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTc2O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/9bb124061c0ae7576bb9f1adcd2479e3","width":960,"height":76},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/XRhT1LmJKathg2xwJuSy4g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xOTA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/9bb124061c0ae7576bb9f1adcd2479e3","width":1200,"height":95}},"lazy":false},{"type":"text","content":"VAUGHAN, Ontario, December 12, 2025--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb" or the "company"), a leading global eye health company dedicated to helping people see better to live better, today announced that it allocated a $2,802,125,000 tranche (the "Replacement Term Loans") of new term B loans, the proceeds of which will be used to refinance all of its outstanding term B loans due 2031 (the "Third Amendment Term Loans") and its outstanding term B loans due 2028 (the "First Incremental Term Loans"). The applicable margin is anticipated to be (i) 3.75% per annum for Replacement Term Loans with an interest rate determined by reference to term SOFR and (ii) 2.75% per annum for Replacement Term Loans with an interest rate determined by reference to the alternate base rate; the margin applicable to the Replacement Term Loans represents a 0.50% per annum reduction for the Third Amendment Term Loans and a 0.25% per annum reduction for the First Incremental Term Loans. The Replacement Term Loans will mature on January 15, 2031, which is same maturity date as the Third Amendment Term Loans and which represents a maturity extension of the First Incremental Term Loans from September 29, 2028.","length":1288,"tagName":"p"},{"type":"text","content":"The foregoing transactions are anticipated to close in the first quarter of 2026; however, there can be no assurances that the company will be able to complete the foregoing transactions on the terms described above or at all.","length":226,"tagName":"p"},{"type":"text","content":"A...